{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:56:38Z","timestamp":1776261398919,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.clinre.2024.102364","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T08:50:40Z","timestamp":1716454240000},"page":"102364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Study of non-alcoholic fatty pancreatic disease among the Egyptian population and the value of serum fatty acid binding protein-1 (FABP-1) as a non-invasive biomarker"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0815-1394","authenticated-orcid":false,"given":"Hussein Hassan","family":"Okasha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9002-2868","authenticated-orcid":false,"given":"Mona A","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3031-3599","authenticated-orcid":false,"given":"Olfat","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5302-4087","authenticated-orcid":false,"given":"Yasmine Abd","family":"Elfatah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9642-4657","authenticated-orcid":false,"given":"Shereen Sadik","family":"El-Sawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8598-7128","authenticated-orcid":false,"given":"Dalia","family":"Abdelfatah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9945-9767","authenticated-orcid":false,"given":"Abeer","family":"Abdellatef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2024.102364_bib0001","unstructured":"Ibrahim, Alaa et al. \u201cReview on pancreatic steatosis detection by imaging modalities.\u201d (2017)."},{"issue":"9","key":"10.1016\/j.clinre.2024.102364_bib0002","doi-asserted-by":"crossref","first-page":"640","DOI":"10.5152\/tjg.2020.19434","article-title":"Evaluation of pancreatic steatosis prevalence and anthropometric measurements using non-contrast computed tomography","volume":"31","author":"Ko\u00e7","year":"2020","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.clinre.2024.102364_bib0003","first-page":"37","article-title":"Pancreatic steatosis and its association with nonalcoholic fatty liver disease evaluated by ultrasonography","volume":"3","author":"Jesuino de Oliveira Andrade","year":"2015","journal-title":"Brazilian J Med Human Health"},{"issue":"44","key":"10.1016\/j.clinre.2024.102364_bib0004","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1556\/650.2022.32638","article-title":"A nem alkoholos hasny\u00e1lmirigy-elzs\u00edrosod\u00e1s klinikai jelent\u0151s\u00e9ge [Lipid accumulation in the pancreas: clinical significance of NAFPD (non-alcoholic fatty pancreas disease)]","volume":"163","author":"Jermendy","year":"2022","journal-title":"Orv Hetil"},{"issue":"23","key":"10.1016\/j.clinre.2024.102364_bib0005","doi-asserted-by":"crossref","first-page":"10878","DOI":"10.1073\/pnas.91.23.10878","article-title":"Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships","volume":"91","author":"Lee","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.clinre.2024.102364_bib0006","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1074\/jbc.271.10.5633","article-title":"Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes","volume":"271","author":"Hirose","year":"1996","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.clinre.2024.102364_bib0007","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1074\/jbc.270.3.1295","article-title":"Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids","volume":"270","author":"Milburn","year":"1995","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.clinre.2024.102364_bib0008","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.gie.2011.01.015","article-title":"A prospective evaluation of fatty pancreas by using EUS","volume":"73","author":"Sepe","year":"2011","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.clinre.2024.102364_bib0009","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1475-2840-12-77","article-title":"Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: case-control retrospective study","volume":"12","author":"Wu","year":"2013","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"10.1016\/j.clinre.2024.102364_bib0010","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.2337\/dc07-0326","article-title":"Pancreatic fat content and beta-cell function in men with and without type 2 diabetes [published correction appears in Diabetes Care. 2008 Apr;31(4):835]","volume":"30","author":"Tushuizen","year":"2007","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.clinre.2024.102364_bib0011","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/oby.2009.352","article-title":"Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans","volume":"18","author":"Hu","year":"2010","journal-title":"Obesity (Silver Spring)"},{"issue":"10","key":"10.1016\/j.clinre.2024.102364_bib0012","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1210\/jc.2009-0584","article-title":"Noninvasive quantification of pancreatic fat in humans","volume":"94","author":"Lingvay","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"15","key":"10.1016\/j.clinre.2024.102364_bib0013","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3748\/wjg.15.1869","article-title":"Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome","volume":"15","author":"Lee","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.clinre.2024.102364_bib0014","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2337\/db06-0859","article-title":"Pancreatic lipomatosis is a structural marker in nondiabetic children with mutations in carboxyl-ester lipase","volume":"56","author":"Raeder","year":"2007","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.clinre.2024.102364_bib0015","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets","volume":"7","author":"Furuhashi","year":"2008","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.clinre.2024.102364_bib0016","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000297","article-title":"Enigmatic ectopic fat: prevalence of nonalcoholic fatty pancreas disease and its associated factors in a Chinese population","volume":"3","author":"Wang","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.clinre.2024.102364_bib0017","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/path.5775","article-title":"Urinary FABP1 is a biomarker for impaired proximal tubular protein reabsorption and is synergistically enhanced by concurrent liver injury","volume":"255","author":"Kawakami","year":"2021","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.clinre.2024.102364_bib0018","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5009\/gnl15155","article-title":"Relationship between controlled attenuation parameter and hepatic steatosis as assessed by ultrasound in alcoholic or nonalcoholic fatty liver disease","volume":"10","author":"Ahn","year":"2016","journal-title":"Gut Liver"},{"issue":"2","key":"10.1016\/j.clinre.2024.102364_bib0019","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1148\/radiology.137.2.7433680","article-title":"Ultrasonic evaluation of normal pancreatic echogenicity and its relationship to fat deposition","volume":"137","author":"Marks","year":"1980","journal-title":"Radiology"},{"key":"10.1016\/j.clinre.2024.102364_bib0020","unstructured":"IBM Corp. (2020). IBM SPSS Statistics for Windows (Version 27.0) [Computer software]. Armonk, NY: IBM Corp."},{"key":"10.1016\/j.clinre.2024.102364_bib0021","article-title":"Non-alcoholic fatty pancreas disease: the unsung disease [published online ahead of print, 2022 Sep 29]","author":"Sevim","year":"2022","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"3","key":"10.1016\/j.clinre.2024.102364_bib0022","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1148\/rg.263055164","article-title":"Multimodality imaging of pancreatic and biliary congenital anomalies","volume":"26","author":"Mortel\u00e9","year":"2006","journal-title":"Radiographics"},{"issue":"2","key":"10.1016\/j.clinre.2024.102364_bib0023","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000022141","article-title":"Pancreas and aging: a study using ultrasonography","volume":"46","author":"Glaser","year":"2000","journal-title":"Gerontology"},{"issue":"5","key":"10.1016\/j.clinre.2024.102364_bib0024","doi-asserted-by":"crossref","first-page":"e62561","DOI":"10.1371\/journal.pone.0062561","article-title":"The association between nonalcoholic fatty pancreas disease and diabetes","volume":"8","author":"Ou","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.clinre.2024.102364_bib0025","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/cen.12862","article-title":"Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat","volume":"83","author":"Della Corte","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.clinre.2024.102364_bib0026","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/MPA.0b013e3181a9d5af","article-title":"Risk factors for hyperechogenic pancreas on endoscopic ultrasound: a case-control study","volume":"38","author":"Al-Haddad","year":"2009","journal-title":"Pancreas"},{"issue":"4","key":"10.1016\/j.clinre.2024.102364_bib0027","doi-asserted-by":"crossref","first-page":"415","DOI":"10.4239\/wjd.v5.i4.415","article-title":"Pancreatic steatosis: is it related to either obesity or diabetes mellitus?","volume":"5","author":"Pezzilli","year":"2014","journal-title":"World J Diabetes"},{"issue":"34","key":"10.1016\/j.clinre.2024.102364_bib0028","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.3748\/wjg.v16.i34.4329","article-title":"Associated factors for a hyperechogenic pancreas on endoscopic ultrasound","volume":"16","author":"Choi","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.clinre.2024.102364_bib0029","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.21608\/amj.2022.240693","article-title":"Mohamed Abu-Mohamed, N. Role of fabp1 as a diagnostic biomarker for non-alcoholic fatty pancreatic disease","volume":"51","author":"El-Sayed Awadallah","year":"2022","journal-title":"Al-Azhar Med J"},{"issue":"Suppl 1","key":"10.1016\/j.clinre.2024.102364_bib0030","first-page":"S49","article-title":"Nonalcoholic fatty pancreas disease","volume":"34","author":"Shah","year":"2019","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clinre.2024.102364_bib0031","doi-asserted-by":"crossref","unstructured":"Sevim B.C., Chela H., Ertugrul H., et al. Non-alcoholic fatty pancreas disease: the unsung disease [published online ahead of print, 2022 Sep 29]. Endocr Metab Immune Disord Drug Targets. 2022;10.2174\/1871530322666220929142905. doi:10.2174\/1871530322666220929142905.","DOI":"10.2174\/1871530322666220929142905"},{"issue":"23","key":"10.1016\/j.clinre.2024.102364_bib0032","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.12998\/wjcc.v9.i23.6624","article-title":"Nonalcoholic fatty pancreas disease: an emerging clinical challenge","volume":"9","author":"Zhang","year":"2021","journal-title":"World J Clin Cases"},{"issue":"3","key":"10.1016\/j.clinre.2024.102364_bib0033","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3390\/jcm11030763","article-title":"Fatty pancreas and pancreatic cancer: an overlooked association?","volume":"11","author":"Khoury","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.clinre.2024.102364_bib0034","doi-asserted-by":"crossref","first-page":"10681","DOI":"10.1038\/s41598-022-14856-w","article-title":"Increased risk of pancreatic cancer in individuals with non-alcoholic fatty liver disease","volume":"12","author":"Park","year":"2022","journal-title":"Sci Rep"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740124000858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740124000858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T15:56:50Z","timestamp":1717343810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740124000858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2210740124000858"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2024.102364","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study of non-alcoholic fatty pancreatic disease among the Egyptian population and the value of serum fatty acid binding protein-1 (FABP-1) as a non-invasive biomarker","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2024.102364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102364"}}